A REVIEW ON DRUG DEVELOPMENT TEAMS
CH. Roshini
, M. Uma devi , J. Vijaya Bhavani , G. Sahitya , D. Sai usha sri
validation, pharmacokinetics, authorization, evaluating, clinical research
Drug development has advanced from workbench chemical synthesis to an automatic and in a few instances digital process where in big numbers of systems may be simulated, synthesized, evaluated and in maximum instances discarded. To identify the behaviour that distinguish the performing drug development teams. The results of the study describe the specific behaviour and strategies used by the teams. These findings suggest a preliminary road map of actions for team members, leaders, and managers. The reader is invited to consider how the outcome of this research might provide benefit for cross-functional teams in other organizations.
Volume 11
Issue 2,
February-2024
Pages : a259-a268
Paper Reg. ID: TIJER_151165
Published Paper Id: TIJER2402032
Downloads: 000271
Research Area: Pharmacy All
Country: pothavarappadu, eluru district, ANDHRA PRADESH, India
ISSN: 2349-9249 | IMPACT FACTOR: 8.57 Calculated By Google Scholar | ESTD YEAR: 2014
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.57 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: TIJER (IJ Publication) Janvi Wave